Jin Medical International ZJYL

Jin Medical International completed Kangma Equity transfer

Foreign issuer report

Form
6-K
Filed
Importance
Routine
  1. Completed transfer of 80% equity in Kangma on Oct 19, 2026
  2. No share issuance required as transfer completed before Oct 31, 2026
  3. Acquisition Agreement remains unchanged

Written from the 6-K on EDGAR. Check the filing before you rely on it.

Get an email when Jin Medical International files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3842 and related industry codes: the same peer list as the financial tables.